Compare Amgen, Inc. (AMGN) vs Canadian Natural Resources Ltd. (CNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Canadian Natural Resources Ltd. — how do they compare? Amgen, Inc. trades at $360.83 (market cap $196.12B), while Canadian Natural Resources Ltd. trades at $43.32 (market cap $86.83B). The key difference: Amgen, Inc. is far larger — about 2.3× Canadian Natural Resources Ltd.'s market cap, and Canadian Natural Resources Ltd. pays the higher dividend (4.21%). Which is the better fit depends on your goals.
| AMGN | CNQ | |
|---|---|---|
Market Cap | $196.12B | $86.83B |
Sector | Health | Energy |
52-Week High | $388.16 | $50.55 |
52-Week Low | $271.18 | $29.31 |
Enterprise Value | $241.41B | $98.06B |
Dividend Yield | 2.77% | 4.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $360.45, down 0.81% on the day, with a bullish technical signal from moving averages and strong fundamental performance including three consecutive quarterly EPS beats. Revenue grew to $36.75B in 2025 with a net income margin of 20.96%, though high debt levels and recent regulatory challenges for Tavneos in Europe present headwinds. Analyst sentiment is positive with 57.9% buy ratings and a consensus price target of $351.29.
The outlook for AMGN is cautiously optimistic, supported by earnings momentum and a diversified product portfolio, but investors face risks from patent expirations, competitive biosimilar pressures, and regulatory setbacks. The stock's current price near consensus target suggests limited near-term upside, requiring careful monitoring of pipeline developments and debt management.
CNQ trades at $43.05, up 2.97% today, with a bullish technical signal from moving averages and strong fundamentals including a 24.5% net income margin and 25.81% ROE. The company has beaten earnings estimates for the last three quarters, with Q2 2026 EPS expected at 1.4. Positive cash flow trends and a 75% analyst buy rating reflect confidence in its operational resilience and shareholder returns via dividends and buybacks.
The outlook for CNQ is positive, supported by record production, disciplined capital allocation, and exposure to stable oil sands assets. Key risks include oil price volatility and rising debt levels, but the stock's attractive valuation and strong free cash flow generation present a compelling opportunity for long-term investors seeking energy sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Canadian Natural Resources Ltd.
Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →
